WRAL Tech Wire

SouthEast Invest Conference To Feature 30 Public Companies

FDA Approves Salix Tablet

Salix Accelerates Stock Option Vesting To Save More Than $40M

Salix Pays Up to $37 Million for Intestinal Product

Salix, InKine Shareholders Approve Merger

Salix Pharmaceuticals to Present at Roth Capital Partners Conference

Drug Manufacturer Salix Suggests Better Treatment for Relief of Cancer Side Effects

Study suggests relief is in site for patients receiving medical treatment for prostate cancer. Drug may have a new purpose.

Earnings: Salix Reports Surge in Profits; Inspire Revenues Climb

Salix produces 13-cent a share profit as sales far outpace expenses; Inspire cuts losses as co-marketed drug sales increase; Icagen reports a loss but notes progress on drugs.

Salix Launches Phase III Trial for New Use of Drug

Salix To Buy Rival Pharmaceutical Firm for $190M

Salix Hires Executive To Lead R&D Efforts

Update: Salix Reports First Profit; Stock Price Soars

Salix Names New Chief Medical Officer

TriVirix Sets Pace for 2004 North Carolina 'Top 50' Tech Firms

Deloitte says leading technology firms increase revenues by 599 percent over five years. TriVirix revenues soar 8881 percent.'Rising Stars' include PowerByHand, LVL7.

Soaring Drug Sales, New Product Have Salix Talking About Profitability

Pharmaceutical firm says Colazal revenue climbs 46 percent, beats analyst expectations. New drug now hitting market. CFO sees $100 million in revenue this year.